In the first quarter, Bayer's adjusted EBITDA was €4.09 billion, estimated at €3.88 billion.
First quarter sales were €13.74 billion, estimated at €13.52 billion.
The adjusted EBITDA margin for the first quarter was 29.7%, estimated at 28.5%.
The first quarter had a negative free cash flow of €1.53 billion, estimated at negative €2.53 billion.
Core earnings per share for the first quarter were €2.49, estimated at €2.34.
At the end of the first quarter, the net debt was €34.26 billion, estimated at €34.79 billion